News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
173 Results
Type
Article (3)
Press Release (170)
Section
Business (43)
Deals (9)
Drug Development (35)
News (72)
Policy (1)
Tag
Alliances (7)
Alzheimer's disease (18)
Cancer (1)
Cell therapy (1)
Clinical research (25)
Earnings (37)
Events (60)
Healthcare (7)
Immunology and inflammation (3)
IPO (9)
Neuroscience (18)
People (2)
Phase I (11)
Phase II (17)
Phase III (2)
Postmarket research (1)
Preclinical (1)
Prostate cancer (1)
Regulatory (1)
United States (16)
Date
Last 30 days (1)
Last 365 days (34)
2024 (34)
2023 (28)
2022 (34)
2021 (30)
2020 (34)
2019 (9)
2018 (1)
2017 (3)
Location
Florida (16)
Texas (1)
173 Results for "inmunebio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer’s Disease
November 13, 2024
·
4 min read
Press Releases
OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower
December 4, 2024
·
7 min read
Press Releases
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
October 25, 2024
·
5 min read
Press Releases
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer’s Disease
September 30, 2024
·
5 min read
Press Releases
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
October 28, 2024
·
6 min read
News
INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
October 11, 2024
·
3 min read
Business
INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024
October 24, 2024
·
4 min read
Press Releases
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference
September 3, 2024
·
3 min read
Press Releases
INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort
September 27, 2024
·
5 min read
Press Releases
INmune Bio Announces $13.0 Million Registered Direct Offering
September 16, 2024
·
5 min read
1 of 18
Next
